[PDF][PDF] Molecular mechanisms of the antitumor effects of anti-CD20 antibodies
M Winiarska, E Glodkowska-Mrowka… - … Biosci (Landmark Ed), 2011 - article.imrpress.com
Introduction 3. Why anti-CD20 mAbs are so effective? 4. Antibodies and molecules targeting
CD20 5. CD20-A target for rituximab 5.1. Gene structure and expression 5.2. Protein …
CD20 5. CD20-A target for rituximab 5.1. Gene structure and expression 5.2. Protein …
Prenyltransferases regulate CD20 protein levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity
Anti-CD20 monoclonal antibodies (mAbs) are successfully used in the management of non-
Hodgkin lymphomas and chronic lymphocytic leukemia. We have reported previously that …
Hodgkin lymphomas and chronic lymphocytic leukemia. We have reported previously that …
[PDF][PDF] Identifikation und Modulation von Resistenzmechanismen gegenüber Rituximab in B-Zell-Non-Hodgkin-Lymphomen
C Stolz - 2008 - researchgate.net
Zusammenfassung B-Zell-Non-Hodgkin-Lymphome (B-NHL) sind eine heterogene Gruppe
klonaler hämatologischer Neoplasien, die aus peripheren B-Lymphozyten hervorgehen. Die …
klonaler hämatologischer Neoplasien, die aus peripheren B-Lymphozyten hervorgehen. Die …